Drugs / MMC
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1/2 | NCT00661583 Comparator | Apr 2008 → Sep 2014 | glaucoma | University of Colorado, Denver | Completed | Met primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MMC | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00661583 ↗ |
| Route | Topical | “topically applied MMC (0.4 mg/mL for 2 min)” PMID 20570237 ↗ Jun 2010 |